Publications
Journal Article (10)
1.
Journal Article
4, 128 (2016)
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathologica Communications 2.
Journal Article
6, 36798 (2016)
Glycation potentiates neurodegeneration in models of Huntington's disease. Scientific Reports 3.
Journal Article
113 (42), pp. E6506 - E6515 (2016)
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 4.
Journal Article
434, pp. 238 - 249 (2016)
Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Molecular and Cellular Endocrinology 5.
Journal Article
6, 31493 (2016)
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports 6.
Journal Article
25 (14), pp. 2959 - 2971 (2016)
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Human Molecular Genetics 7.
Journal Article
12 (6), e1006098 (2016)
C-terminal tyrosine residue modifications modulate the protective phosphorylation of Serine 129 of α-synuclein in a yeast model of Parkinson's disease. PLoS Genetics 8.
Journal Article
31 (6), pp. 782 - 790 (2016)
Glycation in Parkinson's disease and Alzheimer's disease. Movement Disorders 9.
Journal Article
12, e1005995 (2016)
shRNA-based screen identifiers endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity. PLoS Genetics 10.
Journal Article
25 (2), pp. 275 - 290 (2016)
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Human Molecular Genetics